Does Rallies show 13F holders for BKYI?

Yes. Rallies tracks hedge fund and 13F ownership data for BKYI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BKYI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BKYI. It does not provide personalized investment advice.

BKYI (BIO-key International, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

BIO-key International, Inc. Common Stock (BKYI) is a publicly traded Industrials sector company. As of May 21, 2026, BKYI trades at $3.46 with a market cap of $5.76M and a P/E ratio of -3.84. BKYI moved -30.51% today. Year to date, BKYI is -41.33%; over the trailing twelve months it is -56.75%. Its 52-week range spans $3.40 to $36.80. Rallies surfaces BKYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BKYI stock?

Hedge funds tracked by Rallies that own BKYI include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BIO-key International, Inc. Common Stock.

BKYI Key Metrics

Key financial metrics for BKYI
Metric	Value
Price	$3.46
Market Cap	$5.76M
P/E Ratio	-3.84
EPS	$-0.90
Dividend Yield	0.00%
52-Week High	$36.80
52-Week Low	$3.40
Volume	0
Avg Volume	0
Revenue (TTM)	$6.32M
Net Income	$-4.25M
Gross Margin	78.40%

Top Hedge Funds Holding BKYI

Citadel Advisors holds 20.33K shares of BKYI, changed +0.00% as of Dec 31, 2024.

Latest BKYI News

BIO-key Executes 1-for-10 Reverse Split, Nasdaq Suspends Trading; Shares Move to OTC Markets — May 12, 2026
BIO-key Announces 1-for-10 Reverse Split to Regain Compliance, Reduce Shares to 1.1M — Apr 28, 2026
BIO-key Projects 50% H1 Revenue Growth to $5M and Profitability — Apr 16, 2026
BIO-key Books $280K Follow-On Order, Pushes Defense Sales Past $2M — Mar 5, 2026

Recent BKYI Insider Trades

DEPASQUALE MICHAEL W bought 1.62K (~$1.36K) on Sep 16, 2025.
DEPASQUALE MICHAEL W bought 1.62K (~$1.36K) on Sep 16, 2025.
DEPASQUALE MICHAEL W bought 2.50K (~$1.88K) on Sep 15, 2025.

BKYI Analyst Consensus

BKYI analyst coverage data. Average price target: $0.00.

Common questions about BKYI

Who owns BKYI stock?: Hedge funds tracked by Rallies that own BKYI include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BIO-key International, Inc. Common Stock.
Does Rallies show 13F holders for BKYI?: Yes. Rallies tracks hedge fund and 13F ownership data for BKYI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BKYI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BKYI. It does not provide personalized investment advice.